Anatomic Pathology Market Size, Industry Share and Global Forecast 2024 - 2032
Description
The Global Anatomic Pathology Market Size accounted for USD 39.2 Billion in 2023 and is estimated to achieve a market size of USD 73.8 Billion by 2032 growing at a CAGR of 7.4% from 2024 to 2032.
The global anatomic pathology market is experiencing substantial growth, driven by technological advancements, the rising prevalence of chronic diseases, and the increasing demand for accurate diagnostic procedures. Anatomic pathology is a branch of pathology focused on the study of tissue samples, including biopsies, to diagnose diseases, particularly cancers. This market encompasses a wide range of diagnostic techniques, such as histopathology, cytopathology, and molecular pathology, which are crucial in the diagnosis of various diseases, particularly cancer. The growing emphasis on personalized medicine, early disease detection, and precision diagnostics is further fueling the demand for anatomic pathology services, positioning this market as a critical segment in modern healthcare.
The primary driver behind the expansion of the anatomic pathology market is the increasing incidence of chronic diseases, particularly cancer, cardiovascular diseases, and infectious diseases. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, and its prevalence continues to rise. Anatomic pathology plays a crucial role in cancer diagnosis, staging, and prognosis, particularly through techniques such as immunohistochemistry, in situ hybridization, and molecular diagnostics. With early detection being key to improving survival rates, the demand for anatomic pathology services is growing as healthcare providers seek accurate, timely diagnoses to guide treatment decisions.
Anatomic Pathology Market Segmentation
The worldwide market for anatomic pathology is split based on product and service, application, end-use, and geography.
Anatomic Pathology Market By Product and Service
Consumables
Reagents & Antibodies
Probes & Kits
Others
Instruments
Tissue processors
Automatic Stainers
Microtomes & Cryostat
Others
Services
Anatomic Pathology Market By Application
Drug Discovery & Development
Disease Diagnosis
Others
Anatomic Pathology Market By End-use
Hospitals
Diagnostic Laboratories
Research Laboratories
Others
Anatomic Pathology Market Regional Outlook
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Rest of Europe
Asia-Pacific
India
Japan
China
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
The Middle East & Africa
South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)
Anatomic Pathology Market Players
Some of the top anatomic pathology companies offered in our report include PHC Holdings Corporation, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., NeoGenomics Laboratories, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Danaher Corporation, Cardinal Health, and Bio SB.
How Acumen Research and Consulting Reserch Study of helps clients in their decision making:
Creating strategies for new product development
Supporting & Adjust Investment/business decisions
Benchmark and judge own competitiveness
Aiding in the business planning process
Serving as a credible, independent check on company internal forecasts
Supporting acquisition strategies
The global anatomic pathology market is experiencing substantial growth, driven by technological advancements, the rising prevalence of chronic diseases, and the increasing demand for accurate diagnostic procedures. Anatomic pathology is a branch of pathology focused on the study of tissue samples, including biopsies, to diagnose diseases, particularly cancers. This market encompasses a wide range of diagnostic techniques, such as histopathology, cytopathology, and molecular pathology, which are crucial in the diagnosis of various diseases, particularly cancer. The growing emphasis on personalized medicine, early disease detection, and precision diagnostics is further fueling the demand for anatomic pathology services, positioning this market as a critical segment in modern healthcare.
The primary driver behind the expansion of the anatomic pathology market is the increasing incidence of chronic diseases, particularly cancer, cardiovascular diseases, and infectious diseases. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, and its prevalence continues to rise. Anatomic pathology plays a crucial role in cancer diagnosis, staging, and prognosis, particularly through techniques such as immunohistochemistry, in situ hybridization, and molecular diagnostics. With early detection being key to improving survival rates, the demand for anatomic pathology services is growing as healthcare providers seek accurate, timely diagnoses to guide treatment decisions.
Anatomic Pathology Market Segmentation
The worldwide market for anatomic pathology is split based on product and service, application, end-use, and geography.
Anatomic Pathology Market By Product and Service
Consumables
Reagents & Antibodies
Probes & Kits
Others
Instruments
Tissue processors
Automatic Stainers
Microtomes & Cryostat
Others
Services
Anatomic Pathology Market By Application
Drug Discovery & Development
Disease Diagnosis
Others
Anatomic Pathology Market By End-use
Hospitals
Diagnostic Laboratories
Research Laboratories
Others
Anatomic Pathology Market Regional Outlook
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Rest of Europe
Asia-Pacific
India
Japan
China
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
The Middle East & Africa
South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)
Anatomic Pathology Market Players
Some of the top anatomic pathology companies offered in our report include PHC Holdings Corporation, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., NeoGenomics Laboratories, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Danaher Corporation, Cardinal Health, and Bio SB.
How Acumen Research and Consulting Reserch Study of helps clients in their decision making:
Creating strategies for new product development
Supporting & Adjust Investment/business decisions
Benchmark and judge own competitiveness
Aiding in the business planning process
Serving as a credible, independent check on company internal forecasts
Supporting acquisition strategies
Table of Contents
250 Pages
- CHAPTER 1. Industry Overview of Anatomic Pathology Market
- 1.1. Definition and Scope
- 1.2. Summary
- CHAPTER 2. Research Approach
- 2.1. Methodology
- 2.2. Data Source
- CHAPTER 3. Market Dynamics And Competition Analysis
- 3.1. Market Drivers
- 3.2. Restraints and Challenges
- 3.3. Growth Opportunities
- 3.4. Porter’s Five Forces Analysis
- 3.4.1. Bargaining Power of Suppliers
- 3.4.2. Bargaining Power of Buyers
- 3.4.3. Threat of Substitute
- 3.4.4. Threat of New Entrants
- 3.4.5. Degree of Competition
- 3.5. Market Concentration Ratio and Market Maturity Analysis of Anatomic Pathology Market
- 3.5.1. Go To Market Strategy
- 3.5.1.1. Introduction
- 3.5.1.2. Growth
- 3.5.1.3. Maturity
- 3.5.1.4. Saturation
- 3.5.1.5. Possible Development
- 3.6. Technological Roadmap for Anatomic Pathology Market
- 3.7. Value Chain Analysis
- 3.7.1. List of Key Manufacturers
- 3.7.2. List of Customers
- 3.7.3. Level of Integration
- 3.8. Cost Structure Analysis
- 3.8.1. Price Trend of Key Raw Materials
- 3.8.2. Raw Material Suppliers
- 3.8.3. Proportion of Manufacturing Cost Structure
- 3.8.3.1. Raw Material
- 3.8.3.2. Labor Cost
- 3.8.3.3. Manufacturing Expense
- 3.9. Regulatory Compliance
- 3.10. Competitive Landscape, 2023
- 3.10.1. Player Positioning Analysis
- 3.10.2. Key Strategies Adopted By Leading Players
- CHAPTER 4. Manufacturing Plant Analysis
- 4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
- 4.2. R&D Status of Major Manufacturers in 2023
- CHAPTER 5. Anatomic Pathology Market By Product and Service
- 5.1. Introduction
- 5.2. Anatomic Pathology Revenue By Product and Service
- 5.2.1. Anatomic Pathology Revenue (USD Billion) and Forecast, By Product and Service, 2020-2032
- 5.2.2. Consumables
- 5.2.2.1. Consumables Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 5.2.2.2. Reagents & Antibodies
- 5.2.2.2.1. Reagents & Antibodies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 5.2.2.3. Probes & Kits
- 5.2.2.3.1. Probes & Kits Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 5.2.2.4. Others
- 5.2.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 5.2.3. Instruments
- 5.2.3.1. Instruments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 5.2.3.2. Tissue processors
- 5.2.3.2.1. Tissue processors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 5.2.3.3. Automatic Stainers
- 5.2.3.3.1. Automatic Stainers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 5.2.3.4. Microtomes & Cryostat
- 5.2.3.4.1. Microtomes & Cryostat Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 5.2.3.5. Others
- 5.2.3.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 5.2.4. Services
- 5.2.4.1. Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- CHAPTER 6. Anatomic Pathology Market By Application
- 6.1. Introduction
- 6.2. Anatomic Pathology Revenue By Application
- 6.2.1. Anatomic Pathology Revenue (USD Billion) and Forecast, By Application, 2020-2032
- 6.2.2. Drug Discovery & Development
- 6.2.2.1. Drug Discovery & Development Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 6.2.3. Disease Diagnosis
- 6.2.3.1. Disease Diagnosis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 6.2.4. Others
- 6.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- CHAPTER 7. Anatomic Pathology Market By End-use
- 7.1. Introduction
- 7.2. Anatomic Pathology Revenue By End-use
- 7.2.1. Anatomic Pathology Revenue (USD Billion) and Forecast, By End-use, 2020-2032
- 7.2.2. Hospitals
- 7.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 7.2.3. Diagnostic Laboratories
- 7.2.3.1. Diagnostic Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 7.2.4. Research Laboratories
- 7.2.4.1. Research Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- 7.2.5. Others
- 7.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
- CHAPTER 8. North America Anatomic Pathology Market By Country
- 8.1. North America Anatomic Pathology Market Overview
- 8.2. U.S.
- 8.2.1. U.S. Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 8.2.2. U.S. Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 8.2.3. U.S. Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 8.3. Canada
- 8.3.1. Canada Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 8.3.2. Canada Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 8.3.3. Canada Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 8.4. North America PEST Analysis
- CHAPTER 9. Europe Anatomic Pathology Market By Country
- 9.1. Europe Anatomic Pathology Market Overview
- 9.2. U.K.
- 9.2.1. U.K. Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 9.2.2. U.K. Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 9.2.3. U.K. Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 9.3. Germany
- 9.3.1. Germany Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 9.3.2. Germany Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 9.3.3. Germany Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 9.4. France
- 9.4.1. France Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 9.4.2. France Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 9.4.3. France Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 9.5. Spain
- 9.5.1. Spain Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 9.5.2. Spain Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 9.5.3. Spain Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 9.6. Rest of Europe
- 9.6.1. Rest of Europe Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 9.6.2. Rest of Europe Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 9.6.3. Rest of Europe Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 9.7. Europe PEST Analysis
- CHAPTER 10. Asia Pacific Anatomic Pathology Market By Country
- 10.1. Asia Pacific Anatomic Pathology Market Overview
- 10.2. China
- 10.2.1. China Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 10.2.2. China Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 10.2.3. China Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 10.3. Japan
- 10.3.1. Japan Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 10.3.2. Japan Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 10.3.3. Japan Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 10.4. India
- 10.4.1. India Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 10.4.2. India Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 10.4.3. India Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 10.5. Australia
- 10.5.1. Australia Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 10.5.2. Australia Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 10.5.3. Australia Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 10.6. South Korea
- 10.6.1. South Korea Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 10.6.2. South Korea Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 10.6.3. South Korea Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 10.7. Rest of Asia-Pacific
- 10.7.1. Rest of Asia-Pacific Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 10.7.2. Rest of Asia-Pacific Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 10.7.3. Rest of Asia-Pacific Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 10.8. Asia Pacific PEST Analysis
- CHAPTER 11. Latin America Anatomic Pathology Market By Country
- 11.1. Latin America Anatomic Pathology Market Overview
- 11.2. Brazil
- 11.2.1. Brazil Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 11.2.2. Brazil Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 11.2.3. Brazil Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 11.3. Mexico
- 11.3.1. Mexico Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 11.3.2. Mexico Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 11.3.3. Mexico Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 11.4. Rest of Latin America
- 11.4.1. Rest of Latin America Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 11.4.2. Rest of Latin America Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 11.4.3. Rest of Latin America Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 11.5. Latin America PEST Analysis
- CHAPTER 12. Middle East & Africa Anatomic Pathology Market By Country
- 12.1. Middle East & Africa Anatomic Pathology Market Overview
- 12.2. GCC
- 12.2.1. GCC Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 12.2.2. GCC Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 12.2.3. GCC Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 12.3. South Africa
- 12.3.1. South Africa Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 12.3.2. South Africa Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 12.3.3. South Africa Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 12.4. Rest of Middle East & Africa
- 12.4.1. Rest of Middle East & Africa Anatomic Pathology Revenue (USD Billion) and Forecast By Product and Service, 2020-2032
- 12.4.2. Rest of Middle East & Africa Anatomic Pathology Revenue (USD Billion) and Forecast By Application, 2020-2032
- 12.4.3. Rest of Middle East & Africa Anatomic Pathology Revenue (USD Billion) and Forecast By End-use, 2020-2032
- 12.5. Middle East & Africa PEST Analysis
- CHAPTER 13. Player Analysis Of Anatomic Pathology Market
- 13.1. Anatomic Pathology Market Company Share Analysis
- 13.2. Competition Matrix
- 13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
- 13.2.2. New Product Launches and New Product Enhancements
- 13.2.3. Mergers And Acquisition In Global Anatomic Pathology Market
- 13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
- CHAPTER 14. Company Profile
- 14.1. PHC Holdings Corporation
- 14.1.1. Company Snapshot
- 14.1.2. Business Overview
- 14.1.3. Financial Overview
- 14.1.3.1. Revenue (USD Billion), 2023
- 14.1.3.2. PHC Holdings Corporation, 2023 Anatomic Pathology Business Regional Distribution
- 14.1.4. Product /Service and Specification
- 14.1.5. Recent Developments & Business Strategy
- 14.2. Quest Diagnostics Incorporated
- 14.3. Sakura Finetek USA, Inc.
- 14.4. NeoGenomics Laboratories, Inc.
- 14.5. Laboratory Corporation of America Holdings
- 14.6. F. Hoffmann-La Roche AG
- 14.7. Agilent Technologies, Inc.
- 14.8. Danaher Corporation
- 14.9. Cardinal Health
- 14.10. Bio SB
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
